Apheresis Market

Apheresis Market Outlook (2022 to 2032)

The global apheresis market is slated to be valued at US$ 2,990 Million in 2022 and is forecast to reach US$ 8,960 Million by 2032, mounting at a CAGR of 11.6% from 2022 to 2032. From 2017 to 2021 a CAGR of 10.3% was registered for the apheresis market.

Apheresis is a procedure wherein blood is withdrawn from a donor’s body, extraction of one or more blood components such as platelets, plasma, and white blood cells, and transfusing of the remaining blood back into the donor during the procedure or at the end of it.

Various initiatives taken by the government and private companies for the development of advanced medical services and for the delivery of effective treatment have been envisaged to shape the future of apheresis market.

Some of the leading applications for the solutions and products within the global apheresis market include neurology, cancer, cardiovascular diseases, diabetes, renal diseases, hematology, autoimmune diseases, and fibrosis, among others.

The key regions covered in global apheresis market are North America, Middle East and Africa, Europe, Latin America, and Asia Pacific. Among these, North America region led the global apheresis market in 2022, owing to the rising demand for plasma, intended for the production of medicines derived from plasma as well as the presence of well-trenched healthcare and medical infrastructure in the region.

The global apheresis market is primarily driven by the increasing incidence of chronic diseases worldwide, rise in number of platelet donors, and spike in R&D investments made by biotech and pharmaceutical companies.

Report Attributes	Details
Apheresis Market Size 2021	US$ 2,680 Million
Estimated Market Value (2022E)	US$ 2,990 Million
Forecasted Market Value (2032F)	US$ 8,990 Million
Global Market Growth Rate (2022 to 2032)	11.6%CAGR
North America Market Share (2022 to 2032)	45.5%
Key Companies Profiled	Terumo Corporation; Fresenius Kabi AG; B. Braun Melsungen AG; NIKKISO Co., Ltd.; Medica S. p. A.; Asahi Kasei Medical Co. Ltd.; Haemonetics Corporation; Cerus Corporation; Kawasumi Laboratories Inc.; Therakos Inc.

Revenue of Apheresis Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the apheresis market industry research by Fact.MR - market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Apheresis Market industry increased at around 11.6% CAGR, wherein, countries such as the U.S., China, Japan, South Korea, and the UK held a significant share in the global market.

The market for apheresis is expected to grow at an immense rate and show some great results in the upcoming years. The advancement in healthcare and other pharmaceuticals is expected to increase as a result of the increased demand for effective COVID-19 treatments.

The Apheresis Market reached a valuation of US$ 2,680 Million in 2021 and is expected to cross US$ 2,990 Million mark by the end of 2022. Top Procedure, plasmapheresis is expected to grow with a huge CAGR of 10.7% during the forecasted period of 2022 to 2032. From the top application type perspective, Neurology has shown a CAGR of 11.2 % in the historical data and is expected to grow at the rate of 10.9% in the next 10 years.

What’s Driving High Demand for Apheresis Market?

The growing prevalence of diseases boosts the market growth

The increasing number of diseases, a rise in the demand for blood components and their associated safety, technological advancements in the development of new apheresis techniques, and an increase in reimbursement policies and funding for apheresis procedures are expected to drive market growth.

The increasing prevalence of chronic and acute diseases, increasing demand for blood transfusions, and product launches are the major factor driving the growth of the global apheresis equipment market during the forecast period.

Also, the increasing incidence of blood-related disorders combined with technological advancements in devices is expected to boost the apheresis market. Furthermore, increased automation in apheresis machines have led to shorter treatment duration and facilitated related procedures, which is expected to propel the market growth along the forecast period.

Favorable Reimbursement Scenario in Developed Regions Supporting Steady Growth of Apheresis Market

The introduction of new therapy lines such as stem cell therapy, immunoglobulin therapy, and radiotherapy for control and prevention of chronic diseases is inadvertently bolstering the adoption of apheresis procedures, in turn boosting the growth of the global apheresis market.

Governments of North America and Europe are diverting investments towards encouraging the adoption of quality healthcare through various programs such as Medicare, Medicaid, employee insurance programs, and Veterans Health Administration, which alleviates high-cost concerns regarding apheresis procedures.

Understanding the Impact of Underlying Challenges Present in the Apheresis Market

A lack of skilled professionals may impede the growth of the market.

Despite the emergence of new revenue channels for the apheresis market, there are numerous challenges present in the landscape, which could inadvertently narrow growth prospects. A key barrier to growth is the lack of skilled professionals.

Recent times have witnessed an epochal scale of technological changes, which has revolutionized the healthcare industry, and, in turn, its operations. However, scarcity of expert operators leads to an increase in the acquisition cost of well-informed resources, which adds up to the already high cost of apheresis procedures.

Healthcare expenses in developed regions such as North America and Europe are offset through government initiatives and reimbursement programs. However, cost concerns in developing and underdeveloped regions could shrink opportunities for players in the apheresis market, though these present highly lucrative, yet largely untapped markets.

Comparative View of Apheresis Markets

Apheresis Market :

Attributes	Apheresis Market
Growth Factor	Rising incidence of blood-related disorders is expected to boost demand by increasing the usage rates of apheresis machines and kit are anticipated to drive the apheresis market
Opportunity	The advancements in the medical technologies as well as the increasing popularity and population participation in blood donation drives and camps is expected to provide opportunities for the growth of the apheresis market

Therapeutic Apheresis Market :

Attributes	Therapeutic Apheresis Market
Growth Factor	Growing need for several blood components, increasing prevalence of accidents globally, and additional government initiatives toward blood donation are a few primary drivers accelerating the therapeutic apheresis market.
Opportunity	The growing demand for plasma-derived medicines production and well-established healthcare infrastructure and rising need for blood components across the globe is expected to increase the growth of the therapeutics apheresis market.

Plasmapheresis Market :

Attributes	Plasmapheresis Market
Growth Factor	Increasing prevalence of thrombotic thrombocytopenic purpura, Guillain-Barre syndrome, Myasthenia gravis, and diffuse alveolar hemorrhage due to Goodpasture syndrome, hyper viscosity syndrome, chronic inflammatory demyelinating polyneuropathy, and other autoimmune diseases is likely to drive the market growth.
Opportunity	Increasing adoption of plasmapheresis treatment in veterinary healthcare and regular advancements in technologies and reduction in costs is projected to drive the market

Region-Wise Insights

What is the Growth Scenario of North America Apheresis Markets?

Technological advancement in healthcare to boost the market in North America

High technological prowess coupled with government aid supporting research & development activities is increasing the concentration of manufacturers in North America. Advancements in the healthcare sector and progressive improvements in the quality of services have been increasing patients’ reliance on hospitals and clinics.

Besides this, easy access to advanced apheresis products, on the backdrop of ongoing development initiatives undertaken by market players, further expands the patient pool in the region.

Considering these drivers, North America is expected to lead the growth of the apheresis market, with the regional market registering a CAGR of ~10% during the forecast period.

What is the Growth Prospect of the Asia Pacific Apheresis Market?

Increasing prevalence of the chronic disorder in the region to boost the market growth

Asia Pacific is expected to register the highest CAGR during the forecasting period due to the high population base and growing geriatric population in the region. The presence of high unmet needs and rapidly increasing demand for platelets in the region are expected to provide growth opportunities for the apheresis market during the forecast period.

The increasing cases of chronic diseases such as autoimmune diseases and cancer, the growing number of organ donors, and the increasing number of complicated surgical procedures also is supporting the growth of the market in this region.

East Asian countries such as Japan, and China, are some of the leading consumers of apheresis due to which they are holding more than 1/5th of market share in the regional market. The regular advancements in technologies and reduction in costs are likely to boost the Chinese apheresis market which will support to overall apheresis market during 2022 & 2032.

Among other regions, manufacturers in the apheresis market in Japan are taking the technological approach to foster innovation in the development of apheresis products, which is anticipated to strengthen the Asia Pacific apheresis market.

Though reimbursement scenarios are likely to offer coverage in developing countries in future, it is imperative that market players adopt a cost-competitive strategy to achieve better penetration rate of products in these regions.

Category-wise Insights

Based on the procedure which segment holds the highest market value?

Plasmapheresis is expected to be the highest revenue-generating procedure type.

The plasmapheresis segment is the top procedure type segment which grew with a CAGR of 11.1% during 2017 to 2021 and is anticipated to bounce and grow with a CAGR of 10.7% in the forecasted period of 2022 to 2032.

This is partly because of the numerous applications of these procedures in plasma exchange in therapeutic processes. And increasing applications in renal and metabolic diseases, and hematologic and neurologic disorder.

Which is the more promising application type segment?

Neurology accounts for the highest share of the application segment

The neurology segment is expected to witness the fastest growth over the forecast period. According to the National MS Society. Nearly 1 million people are living with MS in the United States, This is more than twice the original estimate and means solutions for MS are now twice as important.

Moreover, the annual incidence of this disease in the U.S. alone amounted to 10,000. Procedural advantages such as lower blood loss and shorter treatment duration owing to complete automation are also expected to have a positive impact on growth.

Start-Ups for Apheresis Market

The new companies that have started to deal with the various kinds of apheresis procedures have been focused on employing smart technologies to enhance productivity as well as efficiency in the field. Some of the recent developments of apheresis market providers are as follows

• Bioelettronica is an equipment manufacturer which produces and sells devices for blood bank handling from collection to separation. New Biomixer BM330 from Bioelettronica has a unique programming capability which makes the blood centres free to choose their own strategy for data registration associated to blood collection and later easily change it according to new global or local regulations or after their own wishes. The device is ready to be connected to a local network for transferring registration and collection data to a central host.

Competitive Landscape

Some of the leading incumbent players and vendors working within the global apheresis market are Terumo Corporation, Fresenius Kabi AG, B. Braun Melsungen AG, NIKKISO Co., Ltd., Medica S. p. A., Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories, Inc., and Therakos, Inc., among others.

Key manufacturers of apheresis are constantly innovating to meet new challenges that are evolving daily. Prominent market players are focusing on a competitive market pricing strategy, which includes the installation of integrated systems along with high-end software.

Apheresis companies are entering into collaborations and partnerships with governments and end-use industries for increasing the installation rate of apheresis systems.

• In January 2020 - Fresenius Kabi inaugurated the expansion of the transfusion and apheresis disposables plant in the Dominican Republic. The company manufactures apheresis sets. These products are used, for example, to collect blood components such as platelets or plasma. Fresenius Kabi undertook the expansion to meet the rising demand for these high-quality disposables used for critically important donations.
• In September 2020 - NIKKISO CO., LTD. participated in the in China Medical Equipment Fair (CMEF) & International Component Manufacturing Design Show (ICMD), a global exhibition for the medical devices market. It will take place in Shanghai during October 19th-22nd, 2020
• In August, 2022 - Haemonetics Corporation announced an agreement with Epic, a leading Electronic Health Record (EHR) system, to offer Haemonetics' SafeTrace Tx® blood bank information system to Epic's global network of hospitals.

Key Segments Covered in Apheresis Industry Survey

• By Product :

  • Devices
  • Disposables

• By Application :

  • Renal Diseases
  • Neurology
  • Haematology
  • Cancer
  • Autoimmune Diseases
  • Cardiovascular Diseases
  • Others (Fibrosis and Diabetes)

• By Procedure :

  • Plasmapheresis
  • Photopheresis
  • LDL Apheresis
  • Plateletpheresis
  • Leukapheresis
  • Erythrocytapheresis
  • Others (Lymphapheresis and extracorporeal immunoadsorption)

• By Technology :

  • Centrifugation
  • Membrane Filtration

• By End User :

  • Hospitals
  • Blood Collection Centres
    • Public
    • Private

• By Region :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East &Africa